v3.25.2
NET LOSS PER SHARE
6 Months Ended
Jun. 30, 2025
NET LOSS PER SHARE  
NET LOSS PER SHARE

20.

NET LOSS PER SHARE

The following table sets forth the basic and diluted net loss per ordinary share computation and provides a reconciliation of the numerator and denominator for the periods presented:

Six Months Ended June 30, 

2025

2024

    

US$

    

US$

Numerator:

 

  

 

  

Net loss attributable to ordinary shareholders

 

(313,038)

 

(459,319)

Accretion of redeemable convertible preferred shares

 

 

(2,979)

Numerator for basic and diluted net loss per ordinary share calculation

 

(313,038)

 

(462,298)

Denominator:

 

 

  

Weighted average number of ordinary shares, basic and diluted1

 

659,335,966

 

616,941,673

Denominator for basic and diluted net loss per ordinary share calculation1

 

659,335,966

 

616,941,673

Net loss per ordinary share attributable to ordinary shareholders

 

 

 – Basic and diluted

 

(0.47)

 

(0.75)

1 Shares outstanding for all periods reflect the adjustment for Recapitalization.

For the purposes of calculating loss per share for the six months ended June 30, 2024, the weighted average number of ordinary shares outstanding used in the calculation has been retrospectively adjusted to reflect the Recapitalization (see note 1(b)), as if the Recapitalization had occurred at the beginning of the earliest period presented. The calculation of basic loss per share excludes 1,417,544 unvested earn-out shares issued to LCAA Sponsor which can only be vested upon meeting certain conditions, and 17,500,000 ordinary shares which the Company has entered into forward contract which required physical settlement by repurchase.

The following outstanding potentially dilutive ordinary share equivalents adjusted to reflect the effect of Recapitalization have been excluded from the computation of diluted net loss per share attributable to ordinary shareholders for the periods presented:

    

Six Months Ended June 30, 

    

2025

    

2024

Share options (i)

 

14,561,421

 

15,622,994

2025 Convertible Notes (ii) (note 15)

86,583,567

2024 Convertible Notes (note 15)

16,716,188

Meritz put option (iii) (note 13)

 

32,500,000

 

50,000,000

Public Warrant (iv) (note 12)

9,054,522

9,054,522

Sponsor Warrant (iv) (note 12)

5,486,784

5,486,784

Total

 

148,186,294

 

96,880,488

(i)For the six months ended June 30, 2025, 14,561,421 vested and unvested share options are not included in the calculation of diluted loss per share as their exercise price was above underlying stock price. For the six months ended June 30, 2024, 15,622,994 vested and unvested share options are not included in the calculation of diluted loss per share due to their antidilutive effect using treasury stock method.
(ii)Represents the number of potentially dilutive ordinary shares equivalent on as-if-converted basis, calculated by the principal and accrued interest of US$190,484 divided by the estimated fair value of ordinary shares as of June 30, 2025, which are not included in the calculation of diluted loss per share due to their antidilutive effect.
(iii)For the six months ended June 30, 2025 and 2024, the exercise of put option issued to Meritz are not included in the calculation of diluted loss per share due to antidilutive effect using reverse treasury stock method.
(iv)For the six months ended June 30, 2025 and 2024, public and sponsor warrants are not included in the calculation of diluted loss per share as their exercise price is above underlying stock price.
(v)The exchange or conversion of Lightning Speed Exchangeable Notes, Kingway Exchangeable Notes and Subsidiary Convertible Note to its respective equity holders as mentioned in note 14 and note 15, respectively, have no impact on the number of the Company’s outstanding ordinary shares. The potential common shares of Lightning Speed, Kingway and Ningbo Robotics, subsidiaries of the Company, were excluded from the computation of diluted net loss per share attributable to ordinary shareholders for the periods presented due to their antidilutive effect.